Immune Response to SARS-CoV-2 Vaccine among Heart Transplant Recipients: A Systematic Review.

Saeed ShoarAdriana C Carolina Prada-RuizGabriel Patarroyo-AponteAshok ChaudharyMohammad Sadegh Asadi

Published in: Clinical medicine insights. Circulatory, respiratory and pulmonary medicine (2022)

HTX recipients demonstrate a weaker immune response to the vaccination against SARS-CoV-2 compared to the general population. Older age, anti-metabolite agents such as mycophenolate mofetil, and vaccination during the first year following the HTX have been indicated as potential determinants of a poor immune response.

Keyphrases

sars cov
immune response
respiratory syndrome coronavirus
dendritic cells
heart failure
toll like receptor
physical activity
middle aged
community dwelling
atrial fibrillation
kidney transplantation
risk assessment
human health
inflammatory response
climate change